Dong-A University Hospital
South Korea
- Country
- South Korea
- Ownership
- Private
- Established
- 1990-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.damc.or.kr/eng/
Clinical Trials
53
Active:2
Completed:18
Trial Phases
3 Phases
Phase 2:7
Phase 3:1
Not Applicable:42
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (50 trials with phase data)• Click on a phase to view related trials
Not Applicable
42 (84.0%)Phase 2
7 (14.0%)Phase 3
1 (2.0%)Carfilzomib, Oral Cyclophosphamide, and Dexamethasone for RRMM
Phase 2
Not yet recruiting
- Conditions
- Multiple Myeloma in RelapseMultiple Myeloma, Refractory
- Interventions
- First Posted Date
- 2023-06-18
- Last Posted Date
- 2023-06-18
- Lead Sponsor
- Dong-A University Hospital
- Target Recruit Count
- 49
- Registration Number
- NCT05909826
Extension of Rapid Response Team Operation Time and Cardiopulmonary Resuscitation Incidence
Completed
- Conditions
- Cardiopulmonary Arrest
- First Posted Date
- 2023-02-06
- Last Posted Date
- 2023-02-06
- Lead Sponsor
- Dong-A University Hospital
- Target Recruit Count
- 142088
- Registration Number
- NCT05712915
- Locations
- 🇰🇷
DongA university hospital, Busan, Seo-gu, Korea, Republic of
Long-term KRd in Relapsed and/or Refractory Multiple Myeloma
- Conditions
- Multiple Myeloma in RelapseMultiple Myeloma, Refractory
- Interventions
- First Posted Date
- 2022-08-10
- Last Posted Date
- 2022-08-10
- Lead Sponsor
- Dong-A University Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT05495620
FOLFIRINOX for 2nd-line Treatment of BTC
Phase 2
Completed
- Conditions
- Biliary Tract Cancer
- Interventions
- First Posted Date
- 2018-12-19
- Last Posted Date
- 2021-02-04
- Lead Sponsor
- Dong-A University Hospital
- Target Recruit Count
- 34
- Registration Number
- NCT03778593
- Locations
- 🇰🇷
Dong-A University Hospital, Busan, Korea, Republic of
Marginal Zone Lymphoma Cohort in Korea
- Conditions
- Lymphoma, B-Cell, Marginal Zone
- First Posted Date
- 2016-04-08
- Last Posted Date
- 2018-04-18
- Lead Sponsor
- Dong-A University Hospital
- Target Recruit Count
- 500
- Registration Number
- NCT02732236
- Locations
- 🇰🇷
Sung Yong Oh, Busan, Korea, Republic of
- Prev
- 1
- 2
- 3
- Next
News
No news found